D. Gilliland

D.
Gary Gilliland is an Independent Director at Laboratory Corporation of America Holdings since 2014.
Memberships include the American Academy of Arts & Sciences, National Academy of Medicine (United States), Association of American Physicians, and American Society of Clinical Investigation.
Former roles include Independent Director at Nuvalent, Inc. from 2021 to 2025; President & Director at Fred Hutchinson Cancer Research Center from 2015 to 2020; Director-Leukemia Program at Dana-Farber from 2002 to 2009; Director-Cancer Stem Cell Program at Harvard Stem Cell Institute in 2009; Director at Twinstrand Biosciences, Inc.; Independent Director at Labcorp Holdings, Inc. from 2024 to 2025; Senior Vice President-Global Oncology Franchise at Merck & Co., Inc. from 2009 to 2013; Senior Vice President-Merck Research Laboratories at The University of Pennsylvania Health System; Investigator at Howard Hughes Medical Institute, Inc. in 2009; Senior Vice President & Head-Oncology Franchise at Merck Research Laboratories Massachusetts LLC from 2009 to 2013; Professor-Stem Cell & Regenerative Biology at Harvard Medical School; Senior Vice President-Merck Research Laboratories at Trustees of the University of Pennsylvania from 2013 to 2015; and Professor & Vice Dean at Perelman School of Medicine from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles; an undergraduate degree from the University of California, Davis; and a doctorate from The University of California, San Francisco.